Home
About
FAQ
History (18)
Diagnostic utility of IMP3 in segregating metastatic melanoma from benign nevi in lymph nodes.
Expression of MACC1 and MET in inflammatory bowel disease-associated colonic neoplasia.
CYLD negatively regulates transforming growth factor-ß-signalling via deubiquitinating Akt.
Metastatic endometrial stromal sarcoma of the lung: importance of immunohistochemical staining, clinical history and imaging studies.
IMP3: a diagnostic and prognostic biomarker in malignant melanoma.
See All 18 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
IMP3: a diagnostic and prognostic biomarker in malignant melanoma.
Xu H. IMP3: a diagnostic and prognostic biomarker in malignant melanoma. Expert Rev Mol Diagn. 2008 Sep; 8(5):557-8.
View in:
PubMed
subject areas
Melanoma
Neoplasm Proteins
Prognosis
RNA-Binding Proteins
authors with profiles
Haodong Xu MD, PhD